KRISTEN BAKER: Open Payments
NPI 1053085696 · GLOVERSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 20 payments from 13 companies in 2025. Trend: 2023 $560 · 2024 $478 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $185 |
| SCPHARMACEUTICALS INC. | 3 | $65 |
| Smith+Nephew, Inc. | 2 | $62 |
| Lilly USA, LLC | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $35 |
| PFIZER INC. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: FUROSCIX, COLLAGENASE SANTYL, JARDIANCE, CAMZYOS, ONPATTRO, ELIQUIS, ZEPBOUND, MOUNJARO.
Industry payments across NY — which companies pay providers there.
